Emerald Health Pharmaceuticals Announces Resignation of CEO and CFO

[ASFN Admin]

SAN DIEGO, CA, July 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat diseases with unmet medical needs, announced today that Jim DeMesa, MD, and Lisa Sanford have resigned from their respective roles as CEO and director, and as CFO. “We thank Jim as a co-founder and chief executive as well as Lisa for their leadership, focused commitment, and execution in building Emerald

Continue reading...